1. Healthcare Expansion
Sustainable Investment
- ✓Vision Oman 2040
- ✓Continuous healthcare infrastructure expansion
- ✓Increasing government investment
- ✓Growing private-sector participation
- ✓Steady healthcare modernization

Healthcare & Pharmaceutical Market Intelligence
Oman represents one of the GCC’s fastest developing healthcare markets, expanding healthcare infrastructure, growing private-sector participation, and sustained government investment.

5.3M
Population
USD 423M
Pharma Imports
USD 303M
Pharma Market
USD 5.1B
Healthcare Market
15–20%
Couple Infertility
Sustainable Investment

Key Market Indicators
USD 303M
Estimated Market Size (2024)
USD 474M
Growth Outlook by 2031
USD 28.25M
Dietary Supplements (2024)
USD 42.45M
Supplements Forecast (2030) • 6.98% CAGR

USD 423M Imports • Net −USD 347M

Oman Study • 259 Omani Couples
53.7%
Female factor infertility (≈5 out of 10 cases)
41.7%
Male factor infertility (≈4 out of 10 cases)
14.3%
Combined male & female factors
21.6%
PCOS among infertile women (tertiary referral study)
4.6–7%
PCOS among women of reproductive age
Sources: Oman Study of 259 Omani couples (unexplained infertility 4.6%) • Omani tertiary referral study • Selected Omani cohorts
Reproductive & Preventive Health

Fertility support

Pre-conception care

Reproductive wellness

Preventive healthcare awareness

Sustained dependence on imported pharmaceuticals

One of the GCC’s most promising long-term healthcare markets

Growing private-sector participation

USD 423M in pharmaceutical imports (2024)

Expanding fertility support demand

Strategically important growth market within the GCC